Delivery Order SPE2DR25D3004-SPE2DR26FXSP4
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,336.62 on December 29, 2025, for the supply of Phenobarbital 130 mg/mL vials. This competitively awarded, firm fixed-price contract is non-set-aside and scheduled for completion by December 30, 2025. AmerisourceBergen Drug Corp will perform this work at its corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $9,470.98 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/ml vials. The contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizes firm fixed pricing with no set-aside designation. This delivery order represents a competitive award under AmerisourceBergen's existing federal contract portfolio and will be performed at the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Phenobarbital 130 mg/mL in vial format, valued at $2,120.38. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procurement procedures. The order is scheduled for ultimate completion on October 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child...
- The Defense Logistics Agency awarded a delivery order valued at $3,837.60 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 65 mg/mL vials. This competitively awarded, non-set-aside delivery order was executed on January 2, 2026, with an ultimate completion date of January 5, 2026. The contract utilizes firm fixed price terms and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,837.60 firm fixed price delivery order to AmerisourceBergen Drug Corp for Phenobarbital 65 mg/ml vial on December 31, 2025, with an ultimate completion date of January 2, 2026. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a $3,285.27 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Phenobarbital 130 mg/ml vials. The contract represents a non-set-aside competitive award with an ultimate completion date of August 29, 2025, and performance location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials with a ceiling value of $2,522.26. This firm fixed-price delivery order was competitively awarded without set-aside designations and is scheduled for completion by January 5, 2026. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, serving federal medical procurement needs across the military and veteran healthcare systems....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Phenobarbital 130 mg/ml vials, with a ceiling value of $1,346.93. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The order is set for ultimate completion by August 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a delivery order, this award likely derives from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Phenobarbital 65 mg/mL vials with a firm fixed price ceiling value of $1,552.57. The order was competitively awarded without a set-aside designation and is scheduled for completion by September 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this requirement from its corporate office location. This delivery order is issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Phenobarbital 130 mg/mL in vial form, with a firm fixed price ceiling value of $4,088.90 and an ultimate completion date of December 23, 2025. This is a non-set-aside competitive award issued as a child delivery order under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXSP4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,492.78 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials on January 6, 2026, with an ultimate completion date of January 7, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The award is issued as a child order under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. AmerisourceBergen serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's comprehensive medical supply chain. The company's federal contract portfolio demonstrates extensive capability in delivering diverse pharmaceutical products including specialty medications, generic drugs, and medical supplies across multiple therapeutic domains. This delivery order for phenobarbital, a barbiturate medication used in neurological treatment and seizure management, exemplifies the company's role in fulfilling essential pharmaceutical commodities required by military treatment facilities and other federal healthcare institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 1/5/26 |